Delivery Order SPE2DB24D3013-SPE2DB25FFQYH
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,669.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 MG tablets (30-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-set-aside contract represents a small-value pharmaceutical delivery executed through AmerisourceBergen's existing indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.08 to AmerisourceBergen Drug Corp for KERENDIA 20 MG tablets (30-count package) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price contract, which was competitively awarded with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a $21,362.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract represents a direct fulfillment order under AmerisourceBergen's existing pharmaceutical supply framework with DLA. Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor antagonist primarily used in the treatment of chronic...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,324.97 for Kerendia 10 mg tablets (90-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.45 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Kerendia (finerenone) is a non-steroidal mineralocorticoid receptor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,760.59 and an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Kerendia is a brand-name pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,792.21 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30 count) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a $5,589.39 delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (90 count) with a completion date of July 18, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed price terms. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,593.24 on August 20, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Kerendia is a prescription medication used in the treatment of chronic kidney disease, representing the type of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Kerendia 10 mg tablets (90-count units) with a ceiling value of $6,552.19. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and is classified as a non-set-aside contract, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...